Supplementary Figure S5 from Phase II Trial of Nivolumab in Metastatic Rare Cancer with Dmmr or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
openalex（2023）
关键词
T Cell Therapy,Tumor Regression,Tumor Microenvironment,T-cell Exhaustion,Biomarkers for Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要